KRAS G12C inhibitor 40
This potent and selective KRAS G12C inhibitor targets the oncogenic mutant protein, effectively suppressing its signaling. It is a valuable research tool for investigating KRAS-driven cancers in both in vitro and in vivo models, supporting studies in oncology and targeted therapy development.
Product Specifications
CAS Number
2660014-14-0
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
O (C[C@H]1N (C) CCC1) C2=NC (=C3C (CN (CC3) C=4C5=C (C=CC4) C=CC (F) =C5Cl) =N2) N6C[C@H] (CC#N) N (C (C=CN7C=NC=N7) =O) CC6
Molecular Formula
C34H36ClFN10O2
Molecular Weight
671.17
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470029-100 1x 100 µL
Fibronectin (TV-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880630-100 1x 100 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942597-100 1x 100 µL
CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/2597), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681149-100 1x 100 µL
CD71 (TFRC/1149), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details